UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response

European journal of endocrinology, 2015-04, Vol.172 (4), p.433

2015

Volltextzugriff (PDF)

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly

Endocrine, 2022-11, Vol.78 (2), p.343-353

2022

Volltextzugriff (PDF)

Machine Learning-Based Texture Analysis in the Characterization of Cortisol Secreting vs. Non-Secreting Adrenocortical Incidentalomas in CT Scan

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.873189-873189

2022

Volltextzugriff (PDF)

Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences

Drugs in context, 2024-05, Vol.13

2024

Volltextzugriff (PDF)

Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells

Experimental cell research, 2011-06, Vol.317 (10), p.1397-1410

2011

Volltextzugriff (PDF)

Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues

Endocrine, metabolic & immune disorders drug targets, 2020, Vol.20 (8), p.1133

2020

Volltextzugriff (PDF)

Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies

Journal of clinical medicine, 2022-03, Vol.11 (7), p.1826

2022

Volltextzugriff (PDF)

Gestione delle endocrinopatie nel paziente talassemico adulto politrasfuso

L'Endocrinologo, 2020, Vol.21 (Suppl 1), p.15-16

2020

Volltextzugriff (PDF)

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

Global & regional health technology assessment (Online), 2024-01, Vol.11 (1), p.1-16

2024

Volltextzugriff (PDF)

New Insights and Methods in the Approach to Thalassemia Major: The Lesson From the Case of Adrenal Insufficiency

Frontiers in molecular biosciences, 2020-01, Vol.6, p.162-162

2020

Volltextzugriff (PDF)

Ageing as a Trait de Union between diabetes and dementia for frailty

CNS & neurological disorders drug targets, 2013-06, Vol.12 (4), p.520

2013

Volltextzugriff (PDF)

La chirurgia del prolattinoma: un cambio di paradigma?

L'Endocrinologo, 2024-06, Vol.25 (3), p.311-315

2024

Volltextzugriff (PDF)

Percutaneous Ethanol Injection Treatment in Benign Thyroid Lesions: Role and Efficacy

Thyroid (New York, N.Y.), 2004-02, Vol.14 (2), p.125-131

2004

Volltextzugriff (PDF)

Management of the aging beta-thalassemia transfusion-dependent population – The Italian experience

Blood reviews, 2019-11, Vol.38, p.100594-100594, Article 100594

2019

Volltextzugriff (PDF)

Primary empty sella and GH deficiency: prevalence and clinical implications

Annali dell'Istituto superiore di sanita, 2012, Vol.48 (1), p.91-96

2012

Volltextzugriff (PDF)

Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors

European journal of endocrinology, 2022-03, Vol.186 (3), p.P1

2022

Volltextzugriff (PDF)

New Perspectives and Challenges Regarding Fertility, Conception and Pregnancy in Hemoglobinopathies. a Multidisciplinary Report of 66 Outcomes

Blood, 2020-11, Vol.136 (Supplement 1), p.22-23

2020

Volltextzugriff (PDF)

Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years

Annals of hematology, 2016-04, Vol.95 (5), p.757-763

2016

Volltextzugriff (PDF)

Linea guida per la terapia dei prolattinomi: Associazione Medici Endocrinologi (AME); Istituto Superiore di Sanità 2022; Associazione Italiana di Neuro-Oncologia (AINO); Associazione Italiana di Neuroradiologia Diagnostica e Interventistica (AINR); Associazione Italiana di Radioterapia e Oncologia Clinica (AIRO); Associazione Nazionale Italiana Patologie Ipofisarie (ANIPI); Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioc); Società Italiana di Endocrinologia (SIE); Società Italiana di Ginecologia e Ostetricia (S

L'Endocrinologo, 2023-08, Vol.24 (4), p.400-411

2023

Volltextzugriff (PDF)

Linea guida per la terapia dei prolattinomi

L'Endocrinologo, 2023-01, Vol.24 (4), p.400-411

2023

Volltextzugriff (PDF)

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes

Journal of experimental & clinical cancer research, 2013-06, Vol.32 (1), p.40-40, Article 40

2013

Volltextzugriff (PDF)

Longitudinal Changes in Endocrine Disease in Thalassemia Major Patients on Different Iron Chelators

Blood, 2015-12, Vol.126 (23), p.4565-4565

2015

Volltextzugriff (PDF)

Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry

Clinical endocrinology (Oxford), 2015-10, Vol.83 (4), p.527-535

2015

Volltextzugriff (PDF)

Longitudinal changes of endocrine and bone disease in adults with [beta]-thalassemia major receiving different iron chelators over 5 years

Annals of hematology, 2016-04, Vol.95 (5), p.757

2016

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(218)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly

Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort

Machine Learning-Based Texture Analysis in the Characterization of Cortisol Secreting vs. Non-Secreting Adrenocortical Incidentalomas in CT Scan

Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences

Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells

Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues

Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies

Gestione delle endocrinopatie nel paziente talassemico adulto politrasfuso

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

New Insights and Methods in the Approach to Thalassemia Major: The Lesson From the Case of Adrenal Insufficiency

Ageing as a Trait de Union between diabetes and dementia for frailty

La chirurgia del prolattinoma: un cambio di paradigma?

Percutaneous Ethanol Injection Treatment in Benign Thyroid Lesions: Role and Efficacy

Management of the aging beta-thalassemia transfusion-dependent population – The Italian experience

Primary empty sella and GH deficiency: prevalence and clinical implications

Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors

New Perspectives and Challenges Regarding Fertility, Conception and Pregnancy in Hemoglobinopathies. a Multidisciplinary Report of 66 Outcomes

Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years

Linea guida per la terapia dei prolattinomi

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes

Longitudinal Changes in Endocrine Disease in Thalassemia Major Patients on Different Iron Chelators

Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry

Longitudinal changes of endocrine and bone disease in adults with [beta]-thalassemia major receiving different iron chelators over 5 years

Suchergebnisse filtern